Phase 1 Clinical Evaluation of the CCR2 Antagonist CCX872-B

被引：0
|
作者：
Bekker, Pirow
Charvat, Trevor
Miao, Shichang
Lohr, Lisa
Sullivan, Timothy
Miao, Zhenhua
Powers, Jay
Jaen, Juan
Schall, Thomas J.
机构：
来源：
DIABETES | 2013年 / 62卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1126-P
引用
收藏
页码：A292 / A293
页数：2
相关论文
共 50 条
  • [31] CCR2: holding B cells back
    Jones, D
    BLOOD, 2004, 104 (04) : 911 - 912
  • [32] Molecular determinants of antagonist interactions with chemokine receptors CCR2 and CCR5
    Dawson, John R. D.
    Kufareva, Irina
    BIOPHYSICAL JOURNAL, 2023, 122 (03) : 185A - 185A
  • [33] Modulation of inflammatory pain in response to a CCR2/CCR5 antagonist in rodent model
    Okamoto, Masayuki
    Suzuki, Takeshi
    Watanabe, Nobuhide
    JOURNAL OF PHARMACOLOGY & PHARMACOTHERAPEUTICS, 2013, 4 (03) : 210 - 212
  • [34] Discovery of a 4-Azetidinyl-1-thiazoyl-cyclohexane CCR2 Antagonist as a Development Candidate
    Zhang, Xuqing
    Hou, Cuifen
    Hufnagel, Heather
    Singer, Monica
    Opas, Evan
    McKenney, Sandra
    Johnson, Dana
    Sui, Zhihua
    ACS MEDICINAL CHEMISTRY LETTERS, 2012, 3 (12): : 1039 - 1044
  • [35] The discovery of MK-0812, a potent and selective CCR2 antagonist
    Yang, Lihu
    Jiao, Richard X.
    Moyes, Chris
    Morriello, Greg
    Butora, Gabor
    Shankaran, K.
    Pasternak, Alexander
    Goble, Steve
    Zhou, Changyou
    MacCoss, Malcolm
    Cumiskey, Anne-Marie
    Peterson, Larry
    Forrest, Mike
    Ayala, Julia M.
    Jin, Hong
    DeMartino, Julie
    Mills, Sander G.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2007, 233 : 580 - 580
  • [36] CCR2 Antagonist Inhibits Neointimal Proliferation Post CoronaryStent Deployment
    Teramoto, Tomohiko
    Ikeno, Fumiaki
    Nakatani, Daisaku
    Otake, Hiromasa
    Lyons, Jennifer K.
    Sullivan, Tim
    Jaen, Juan
    Schall, Tom
    Tio, Fermin
    Yeung, Alan C.
    Fearon, William F.
    CIRCULATION, 2010, 122 (21)
  • [37] Efficacy of a Small Molecule CCR2 Antagonist in Experimental Model of Chronic Pancreatitis
    Xue, Jing
    Zhao, Qinglan
    Sharma, Vishal
    Kalisiak, Jaroslav
    Zeng, Yibin
    Krasinski, Antoni
    Zhang, Penglie
    McMahon, Jeff
    Campbell, James J.
    Charo, Israel
    Schall, Thomas
    Habtezion, Aida
    GASTROENTEROLOGY, 2016, 150 (04) : S917 - S917
  • [38] CCR2 Antagonist Inhibits Neointimal Proliferation Post Coronary Stent Deployment
    Teramoto, Tomohiko
    Ikeno, Fumiaki
    Nakatani, Daisaku
    Otake, Hiromasa
    Lyons, Jennifer K.
    Sullivan, Tim
    Jaen, Juan
    Schall, Tom
    Tio, Fermin
    Fearon, William F.
    Yeung, Alan C.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 56 (13) : B91 - B91
  • [39] CCR2/CCR5 antagonist cenicriviroc reduces colonic inflammation and fibrosis in experimental colitis
    Song, Xin
    Jiang, Chensheng
    Yu, Mengli
    Lu, Chao
    He, Xinjue
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2024, 39 (08) : 1597 - 1605
  • [40] Use of modeling and crystallography to understand CCR2 antagonist SAR and receptor binding
    Tebben, Andrew
    Carter, Percy
    Cherney, Robert
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2018, 255
12345